Related Experiment Video
Updated: Sep 8, 2025
Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer
Published on: May 10, 2024
A call to action: MTHFR polymorphisms should not be a part of inherited thrombophilia testing
Thomas G Deloughery1, Beverley J Hunt2, Geoffrey D Barnes3
1Division of Hematology/Medical Oncology Knight Cancer Center Oregon Health & Science University Portland Oregon USA.
Abstract:
Testing for polymorphisms in the methylenetetrahydrofolate reductase (MTHFR) gene is still a standard part of thrombophilia testing in many laboratories. However, it is clear that these polymorphisms are not risk factors for arterial or venous thrombosis and therefore should not be part of thrombophilia testing. Eliminating MTHFR from thrombophilia testing will reduce patient concerns and health care costs.
Related Concept Videos
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
01:31Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
01:49Probability Laws